Piramal Pharma Ltd to Hold Board Meeting for Q1 Results; Trading Window Remains Closed
Piramal Pharma Ltd has scheduled a Board of Directors meeting to review and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ending June 30, 2026. The company announced that this board meeting is set to take place on Wednesday, July 29, 2026.During the meeting, the directors are scheduled to consider the financial performance of the company as per the results released for the specified quarter.In addition to the update regarding the board meeting, Piramal Pharma Ltd provided information concerning its trading window status. The company confirmed that the trading window, which had closed on Wednesday, July 1...